Skip to main content
Clinical Trials/NCT03829293
NCT03829293
Completed
Not Applicable

High-Flow Nasal Oxygenation Versus Standard Oxygenation in Gastrointestinal Endoscopy With Sedation. A Prospective Multicenter Randomized Study

Centre Hospitalier Régional d'Orléans3 sites in 1 country380 target enrollmentMarch 26, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastrointestinal Endoscopy
Sponsor
Centre Hospitalier Régional d'Orléans
Enrollment
380
Locations
3
Primary Endpoint
Incidence of hypoxia
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study is a randomized controlled trial comparing high-flow nasal oxygen therapy (HFNO) versus standard oxygen therapy (nasal prongs, nasopharyngeal catheter or standard face mask) during gastrointestinal (GI) endoscopy with sedation to reduce the incidence of hypoxia.

Detailed Description

Hypoxemia is the most common complication during a gastrointestinal endoscopy with sedation. Oxygenation is usually applied during the procedure to prevent the occurrence of desaturation. Conventional oxygen is typically administered by conventional nasal cannula, by nasopharyngeal catheter or by a facemask with mild flow of oxygen. The flow of standard oxygen is limited to 15L/min. High-flow nasal cannula oxygenation is a new method of humidified and heated oxygenation with a higher flow rates (up to 70L/min). The primary outcome will be the incidence of hypoxia defined by pulsed saturation with oxygen (SpO2) ≤92%. The investigator's hypothesis is that high-flow nasal oxygen therapy will decrease the frequency of hypoxemia during gastrointestinal endoscopy under sedation.

Registry
clinicaltrials.gov
Start Date
March 26, 2019
End Date
September 9, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age greater than or equal to 18 years
  • Having GI endoscopy expected under sedation
  • At risk of hypoxia defined by (one of the item): an underlying cardiac disease ; an underlying respiratory disease ; age greater than or equal to 60 years ; ASA II, III or ASA IV ; with an body mass index greater or equal to 30 (kg/m²); with sleep apnea syndrome diagnosed or suspected with a STOP-BANG score ≥ 3

Exclusion Criteria

  • Age below 18
  • Emergency GI endoscopy
  • Need of intubation for the procedure
  • Patient with chronic oxygen treatment
  • Patients with tracheostomy
  • Pregnancy, breastfeeding
  • Not affiliated to French social security

Outcomes

Primary Outcomes

Incidence of hypoxia

Time Frame: Duration of GI endoscopy procedure under sedation, an expected average of 2 hours

SpO2 ≤ 92%

Secondary Outcomes

  • Failure of the endoscopic procedure(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Serious adverse event rate(24 hours)
  • Incidence of hypoxia in the recovery room(Length of stay in the recovery room, an expected average of 2 hours)
  • Incidence of apnea during the procedure(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Incidence of hypoxia with SpO2 ≤ 90%(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Prolonged hypoxia during the procedure(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Temporal course of SpO2(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Duration of the endoscopic procedure(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Duration of sedation(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Severe hypoxia during the procedure(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Temporal course of heart rate(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Incidence of bradycardia(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Incidence of need for mechanical respiratory support(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Length of stay in the recovery room(Length of stay in the recovery room, an expected average of 2 hours)
  • Incidence of severe hypoxia(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Modification of oxygenation during the procedure(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • The need of intervention by the anesthesia team(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Temporal course of respiratory rate(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Temporal course of arterial blood pressure(Duration of GI endoscopy procedure under sedation, an expected average of 2 hours)
  • Need of hospitalisation(24 hours)

Study Sites (3)

Loading locations...

Similar Trials